We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+13.4%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$1.67B
(+18%)
Cap. Flow
+$806M
Cap. Flow
% of AUM
7.42%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
678
New
211
Increased
171
Reduced
126
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ERF
Enerplus Corporation
ERF
|
+$91.2M |
| 2 |
TE Connectivity
TEL
|
+$81.6M |
| 3 |
Palo Alto Networks
PANW
|
+$78.9M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$75.6M |
| 5 |
Honeywell
HON
|
+$70.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$113M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
+$88.1M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$70.1M |
| 5 |
Synopsys
SNPS
|
+$64.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.5% |
| 2 | Technology | 22.75% |
| 3 | Industrials | 9.82% |
| 4 | Energy | 8.34% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Revvity
RVTY
$12.7B
| $8M | 0.07% |
+76,185
| New | +$8.11M |
|
302
ICU Medical
ICUI
$4.16B
| $7.89M | 0.07% |
+73,507
| New | +$7.31M |
|
|
RCM
303
DELISTED
R1 RCM Inc. Common Stock
RCM
| $7.86M | 0.07% |
+610,222
| New | +$7.09M |
|
|
MASI
304
DELISTED
Masimo
MASI
| $7.8M | 0.07% |
53,146
-229,129
| -81% | -$29.6M |
|
305
Spectrum Brands
SPB
$2.03B
| $7.72M | 0.07% |
+86,746
| New | +$7.08M |
|
306
Structure Therapeutics
GPCR
$3.74B
| $7.71M | 0.07% |
179,892
+673
| +0.4% | +$28.4K |
|
307
Viridian Therapeutics
VRDN
$2.49B
| $7.69M | 0.07% |
+438,922
| New | +$8.51M |
|
308
Broadcom
AVGO
$2T
| $7.68M | 0.07% |
+57,920
| New | +$7.18M |
|
|
EGLE
309
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $7.63M | 0.07% |
122,096
+104,076
| +578% | +$6.07M |
|
310
International Flavors & Fragrances
IFF
$21.6B
| $7.63M | 0.07% |
88,685
-98,777
| -53% | -$7.93M |
|
311
Flowserve
FLS
$10B
| $7.62M | 0.07% |
166,921
+120,865
| +262% | +$5.09M |
|
312
Rhythm Pharmaceuticals
RYTM
$7.72B
| $7.46M | 0.07% |
172,207
+97,357
| +130% | +$4.26M |
|
313
Edgewise Therapeutics
EWTX
$4.78B
| $7.39M | 0.07% |
405,132
+920
| +0.2% | +$14.6K |
|
314
Western Digital
WDC
$156B
| $7.34M | 0.07% |
142,242
-1,022,678
| -88% | -$44.8M |
|
315
Tencent Music
TME
$15.7B
| $7.29M | 0.07% |
651,308
+47,434
| +8% | +$465K |
|
316
US Physical Therapy
USPH
$1.16B
| $7.28M | 0.07% |
+64,540
| New | +$6.44M |
|
|
ACLX
317
DELISTED
Arcellx
ACLX
| $7.24M | 0.07% |
104,060
| – | – |
|
318
Crinetics Pharmaceuticals
CRNX
$8.9B
| $7.18M | 0.07% |
153,395
+3,395
| +2% | +$133K |
|
319
GitLab
GTLB
$6.03B
| $7.12M | 0.07% |
+122,048
| New | +$8M |
|
320
Procter & Gamble
PG
$342B
| $7.11M | 0.07% |
+43,799
| New | +$6.87M |
|
321
Enliven Therapeutics
ELVN
$4.31B
| $6.96M | 0.06% |
395,686
| – | – |
|
322
Biomea Fusion
BMEA
$90.4M
| $6.95M | 0.06% |
464,573
| – | – |
|
323
American International
AIG
$42.4B
| $6.93M | 0.06% |
+88,640
| New | +$6.33M |
|
|
VERV
324
DELISTED
Verve Therapeutics
VERV
| $6.92M | 0.06% |
521,112
+23
| +0% | +$305 |
|
|
SLRN
325
DELISTED
ACELYRIN
SLRN
| $6.89M | 0.06% |
1,021,204
+72,645
| +8% | +$552K |
|
Similar funds
TCIIS
UIM
VAI
KK
Woodline Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Woodline Partners held 678 positions worth $10.9B, up 18% from $9.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Woodline Partners deployed $806M of net new capital in Q1 2024, opening 211 new positions and adding to 171 existing holdings. Its largest new stake was Enerplus Corporation: 5,602,613 shares worth $110M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $110M trimmed.
- Woodline Partners's largest Q1 2024 buy was Enerplus Corporation: 5,602,613 shares worth $110M.
- Woodline Partners added most to TE Connectivity in Q1 2024, an estimated $81.6M increase.
- Woodline Partners's biggest Q1 2024 reduction was AbbVie, cutting an estimated $110M.
- Woodline Partners fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $113M.
- Woodline Partners's ten largest holdings make up 14% of its $10.9B portfolio in Q1 2024.
- Woodline Partners opened 211 new positions and closed 150 in Q1 2024.
- Woodline Partners's portfolio value rose 18% quarter-over-quarter to $10.9B.
Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.